Piramal Pharma Limited has informed the Exchange regarding a press release dated March 20, 2025, titled "Press Release - Piramal Critical Care and BrePco announces MHRA approval for Neoatricon? in the UK".
Piramal Pharma Limited has informed the Exchange regarding a press release dated March 20, 2025, titled "Press Release - Piramal Critical Care and BrePco announces MHRA approval for Neoatricon? in the UK".